HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
MDL 29311
structure given in first source
Also Known As:
4,4'-(methylenebis(thio))bis(2,6-bis(1,1-dimethylethyl))phenol; MDL 29,311; MDL-29311
Networked:
2
relevant articles (
0
outcomes,
0
trials/studies)
Bio-Agent Context: Research Results
Organic Chemicals: 133
Hydrocarbons: 1713
Cyclic Hydrocarbons: 97
Aromatic Hydrocarbons: 291
Benzene Derivatives: 17
Phenols: 677
Probucol: 701
MDL 29311: 2
Related Diseases
1.
Atherosclerosis
09/01/1991 - "
Attenuation of atherosclerosis in a modified strain of hypercholesterolemic Watanabe rabbits with use of a probucol analogue (MDL 29,311) that does not lower serum cholesterol.
"
2.
Hypoglycemia (Reactive Hypoglycemia)
08/01/1993 - "
In STZ-induced (65 mg/kg) diabetic rats, MDL 29311 attenuated the increase in plasma nonesterified fatty acids during an 18-h fast; had little or no effect on glucagon, pyruvate, lactate, beta-hydroxybutyrate, acetoacetate, or cholesterol; and did not induce hypoglycemia in rats fasted up to 64 h.
"
Related Drugs and Biologics
1.
Cholesterol
2.
3-Hydroxybutyric Acid (beta-Hydroxybutyric Acid)
3.
Lactic Acid (Lactate)
4.
Pyruvic Acid (Pyruvate)
5.
Probucol (Lorelco)
6.
Glucagon (Glukagon)
7.
Nonesterified Fatty Acids (NEFA)
8.
acetoacetic acid (acetoacetate)